Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Carisma Therapeutics Inc. (NASDAQ: CARM) and OrthoCellix, Inc. is fair to Carisma shareholders. Upon completion of ...
Shares of Carisma Therapeutics Inc. (CARM) have been struggling lately and have lost 12.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...
Carisma Therapeutics Inc. (CARM) closed the last trading session at $6.74, gaining 6.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback